1.625
price up icon0.89%   0.015
 
loading

Pyxis Oncology Inc Azioni (PYXS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
2.82
- - - -
Operating Expenses
1.50%
22.57
22.91 40.07 23.75 20.03
Benefits Costs and Expenses
1.26%
20.89
21.16 37.73 21.20 17.30
Costs And Expenses
1.26%
20.89
21.16 37.73 21.20 17.30
Operating Income/Loss
13.81%
-19.75
-22.91 -40.07 -23.75 -20.03
Nonoperating Income/Loss
4.38%
1.679
1.756 2.334 2.551 2.731
Income/Loss From Continuing Operations Before Tax
14.59%
-18.07
-21.16 -37.73 -21.20 -17.30
Income Tax Expense/Benefit
0.283
- -2.164 - -
Income/Loss From Continuing Operations After Tax
13.25%
-18.35
-21.16 -35.57 -21.20 -17.30
Net Income/Loss
13.25%
-18.35
-21.16 -35.57 -21.20 -17.30
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.42%
61.92
61.05 0.9338 60.72 60.50
Diluted Average Shares
1.42%
61.92
61.05 0.9338 60.72 60.50
Basic Earnings Per Share
14.29%
-0.30
-0.35 -0.59 -0.35 -0.29
Diluted Earnings Per Share
14.29%
-0.30
-0.35 -0.59 -0.35 -0.29
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.10
price up icon 0.76%
$27.54
price up icon 0.53%
$26.39
price up icon 10.63%
$110.50
price up icon 7.16%
$143.88
price up icon 0.80%
biotechnology ONC
$338.00
price up icon 6.13%
Capitalizzazione:     |  Volume (24 ore):